buserelin has been researched along with Carcinoma, Anaplastic in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 9 (33.33) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petas, A; Pettersson, B; Sandow, J; Varenhorst, E | 1 |
| Ackman, D; Comaru-Schally, AM; Fazekas, AT; Labrie, F; Mehta, A; Schally, AV; Stellos, A; Tolis, G | 1 |
| Horibe, S; Imai, A; Takagi, A; Tamaya, T | 1 |
| de Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, U; Sylvester, R | 1 |
| Brower, ST; Hollander, VP; Redding, TW; Schally, AV | 1 |
| Baldelli, S; Cellerino, R; Menichetti, ET; Miseria, S; Murer, B; Torresi, U; Tummarello, D | 1 |
| Horlbeck, R; Jurincic, CD; Klippel, KF | 1 |
| Kuhn, JM | 1 |
| Jacobi, GH | 1 |
| Girsch, E; Kratzik, C; Kuber, W; Spona, J; Treu, T; Zeillinger, R | 1 |
| Bono, A; De Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, DW; Robinson, M; Smith, PH; Sylvester, R | 1 |
| Braf, Z; Greenstein, A; Kaver, I; Matzkin, H | 1 |
| Blom, JH; de Jong, FH; Hirdes, WH; Krauss, B; Kwekkeboom, DJ; Sandow, J; Schröder, FH; van't Veen, AJ | 1 |
| Hansen, JB; Hansen, RI; Hvidt, V; Iversen, HG; Iversen, P; Mogensen, P; Pedersen, T; Rose, C; Stage, JG | 1 |
| Opsomer, RJ; Van Cangh, PJ | 1 |
| Calle Fernández, JR; Rubio Herrera, MA | 1 |
| Debruyne, FM; Fernandez del Moral, P; Geboers, AD | 1 |
| Griffiths, K; Kaisary, AV; Peeling, WB; Ryan, PG; Turkes, A | 1 |
| al-Abadi, H; Borgmann, V; Nagel, R | 1 |
| Debruyne, FM; Denis, L; Lunglmayer, G; Mahler, C; Newling, DW; Richards, B; Robinson, MR; Smith, PH; Weil, EH; Whelan, P | 1 |
| Cirulli, C; Drago, JR; Nesbitt, JA | 1 |
| Bonichon, F; Coste, P; Lamarche, P; Mage, P; Mauriac, L; Richaud, P | 1 |
| Boulton, J; Croxson, MS; Harvey, V; Holdaway, IM; Ibbertson, HK; Knox, BS | 1 |
| Hickey, D; Soloway, MS; Todd, B | 1 |
| Akimoto, S; Fuse, H; Igarashi, T; Murakami, S; Shimazaki, J; Zama, S | 1 |
| Watanabe, H | 1 |
| Denis, L; Lunglmayr, G; Mahler, C; Robinson, MR; Stitch, R; Walker, K | 1 |
9 trial(s) available for buserelin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Combined Modality Therapy; Drug Administration Routes; Drug Implants; Erectile Dysfunction; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Libido; Male; Middle Aged; Neoadjuvant Therapy; Prostate; Prostatic Neoplasms; Sexual Behavior; Testosterone; Time Factors | 2006 |
Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis o
Topics: Acid Phosphatase; Administration, Intranasal; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Cause of Death; Cyproterone Acetate; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Subcutaneous; Male; Middle Aged; Orchiectomy; Pain Measurement; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Survival Rate | 1991 |
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.
Topics: Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Carcinoma; Combined Modality Therapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Liver Function Tests; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Survival Rate | 1990 |
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Buserelin; Carcinoma; Combined Modality Therapy; Delayed-Action Preparations; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms | 1989 |
LHRH-analogues therapy for metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Goserelin; Humans; Male; Middle Aged; Netherlands; Prostatic Neoplasms; Testosterone | 1988 |
A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Clinical Trials as Topic; Combined Modality Therapy; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1988 |
Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Buserelin; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Cytophotometry; DNA, Neoplasm; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Remission Induction | 1988 |
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Topics: Buserelin; Carcinoma; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone; Time Factors | 1985 |
18 other study(ies) available for buserelin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
Topics: Buserelin; Carcinoma; Estradiol; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1982 |
Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma.
Topics: Adenosine Diphosphate Ribose; Adenosine Triphosphate; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Endometrial Neoplasms; Enzyme Activation; Female; Gonadotropin-Releasing Hormone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Pertussis Toxin; Phosphorylation; Receptors, LHRH; Virulence Factors, Bordetella | 1997 |
Differential effects of LHRH and somatostatin analogs on human breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma; Cell Division; Estrogens; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; In Vitro Techniques; Somatostatin; Triptorelin Pamoate; Tumor Cells, Cultured | 1992 |
Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
Topics: Buserelin; Carcinoma; Flutamide; Goserelin; Humans; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Prostatic Neoplasms | 1991 |
[Hormonal treatments of prostate cancer].
Topics: Androgen Antagonists; Buserelin; Carcinoma; Diethylstilbestrol; Drug Therapy, Combination; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms | 1990 |
LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade.
Topics: Antineoplastic Agents; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1990 |
[Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Buserelin; Carcinoma; Drug Implants; Goserelin; Humans; Male; Middle Aged; Organ Size; Prospective Studies; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testis; Testosterone | 1990 |
Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Buserelin; Carcinoma; Clinical Enzyme Tests; Drug Evaluation; Follow-Up Studies; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 1989 |
Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patients.
Topics: Aged; Buserelin; Carcinoma; Delayed-Action Preparations; Drug Implants; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1989 |
Treatment of advanced carcinoma of the prostate with a depot luteinizing hormone-releasing hormone analogue (ICI-118630).
Topics: Aged; Buserelin; Carcinoma; Delayed-Action Preparations; Diethylstilbestrol; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1987 |
[Treatment of carcinoma of the prostate with analogs of LHRH].
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Drug Administration Schedule; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1988 |
Effect of long-acting LHRH analog (Zoladex) on prostate cancer: evaluated by transrectal ultrasonography.
Topics: Aged; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Ultrasonography | 1988 |
Clinical study of an LH-RH agonist (ICI 118.630, Zoladex) in the treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction | 1988 |
Zoladex treatment of symptomatic prostatic carcinoma.
Topics: Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
[Treatment of prostatic cancer with an LH-RH analog].
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms | 1986 |
The Japanese experience: use of transrectal ultrasound in the evaluation of tumor response to various treatment modalities.
Topics: Animals; Buserelin; Carcinoma; Dogs; Estramustine; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Orchiectomy; Prostate; Prostatic Neoplasms; Testosterone; Ultrasonography | 1987 |